The Global Vascular Embolotherapy Market was estimated to be worth USD 3.8 Billion in 2022 and is projected to reach a value of USD 7.03 Billion by 2030, growing at a CAGR of 6% during the outlook period 2023-2030.
In contrast, to open surgery, embolization is a less invasive treatment that plugs one or more blood arteries or unusual vascular pathways. Blood vessel blockage is made possible via embolization techniques, preventing invasive surgery. Embolization is a procedure that can stop arterial bleeding as well as restrict blood arteries for various purposes, such as treating malignancies, rerouting blood flow, or reducing vascular abnormalities, among others. In interventional radiology, embolization is a common and effective technique. Vascular embolization providers employ the power of mechanical occlusion to stop the flow of blood via a blood artery or vascular area. Vascular embolization agents provide several advantages, including a high success rate, seldom use of generic anesthetics, faster recovery times, a low risk of infection, and no scarring. Market participants are expected to see a huge increase thanks to rising demand for less invasive procedures. For instance, according to the American College of Cardiology, in the United States, around 1.2 million angioplasties were performed in a single year in 2020. Additionally, a sizable patient group is projected to be drawn in by hospitals' high levels of accessibility and cost compared to specialty clinics. The primary driving forces behind the development of the global vascular embolotherapy market are the rising prevalence of vascular illnesses, technical advancements in embolization products and procedures, increasing research and development efforts, and a growing desire for less invasive methods. The rise in minimally invasive procedures combined with rising rates of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids, as well as rising public-private organization research funding, grants, and investment, will drive the market's expansion over the coming years.
Global Vascular Embolotherapy Market Drivers:
Rising Global Incidence of Vascular Ailments Fuels Growth in the Vascular Embolotherapy Market:
Global vascular disease incidence is expected to rise throughout the course of the projected period, driving the growth of the global vascular embolotherapy market. Any situation that affects the blood vessel community is a vascular disease. They can be severe and are common. For instance, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) claim an estimated 17.9 million lives annually, making them the leading cause of mortality worldwide. This accounts for 35% of fatalities worldwide.
Embolization Products and Strategies: Driving Growth in the Vascular Embolotherapy Market:
Over the projected period, it is predicted that improvements in embolization products and tactics will fuel even greater growth in the global vascular embolotherapy market. For instance, Terumo Medical Corporation announced the debut of its AZUR Vascular Plugin in July 2021. It is the first and only plug-like device with a micro-catheter to occlude arteries with a diameter of up to 8 mm. The new component of Terumo's reliable embolization portfolio is suggested for usage to reduce or stop the rate of blood drift in peripheral vascular arteries.
Global Vascular Embolotherapy Market Challenges:
Vascular embolotherapy is characterized by elaborate processes and apparatus, which can make training and application difficult for medical personnel. Despite improvements, there is still little knowledge about vascular embolotherapy's advantages and accessibility among medical professionals and patients. This may limit the market's ability to expand. Products used in vascular embolotherapy must pass strict regulatory clearances and safety evaluations, which might delay product introductions and raise total development costs. There is a shortage of skilled surgeons (including radiologists and neurosurgeons) in the healthcare industry. By 2025, the US is expected to have a shortage of 41,000 general surgeons, according to the Association of American Medical Colleges (US) (Source: Association of American Medical Colleges US, 2017). By 2025, there will be a shortage of more than 2,300 medical oncologists in the US (Source: Journal of Global Oncology). Similarly to this, there is a severe lack of oncologists, radiotherapists, and surgical oncologists in India. There is just one oncologist for every 2,000 cancer patients in the nation, which has 1.8 million cancer patients. The adoption of embolotherapy techniques is anticipated to be impacted by the global scarcity of oncologists and radiologists. Various locations have various vascular embolotherapy reimbursement regulations and coverage, which causes confusion and financial hardship for patients and healthcare professionals alike.
COVID-19 Impact on Global Vascular Embolotherapy Market:
The pandemic caused a huge disruption in the world's healthcare systems, postponing or cancelling a large number of non-emergency operations and surgeries. As a result, the demand for vascular embolotherapy operations temporarily decreased. The epidemic made it clear how crucial it is to cut down on hospital stays and infection risks. As a result, the importance of minimally invasive techniques, such as vascular embolotherapy, as alternatives to more invasive operations has grown. The market may eventually be driven by this movement in preferences. Before the outbreak in Wuhan (China) in December 2019, COVID-19 was mostly unknown but quickly turned into a global epidemic. The COVID-19 epidemic has increased the strain on the world's healthcare systems. Companies increased their R&D efforts to develop vaccinations and medications to combat the virus. The COVID-19 epidemic had an effect on the market for vascular embolotherapy since hospitals' and doctors' access to care for people with non-COVID symptoms had been severely curtailed owing to social exclusion policies implemented worldwide. The pandemic caused a huge disruption in the world's healthcare systems, postponing or cancelling a large number of non-emergency operations and surgeries. As a result, the demand for vascular embolotherapy operations temporarily decreased. Increased Focus on Minimally Invasive Therapies: The pandemic brought to light the value of lowering hospital stays and infection risk. As a result, the importance of minimally invasive techniques, such as vascular embolotherapy, as alternatives to more invasive operations has grown. The market may eventually be driven by this movement in preferences.
Global Vascular Embolotherapy Market Recent Developments:
In March 2022, Expanding the vascular embolotherapy indications has been the subject of continuing research and development. The use of embolization procedures in the treatment of liver cancer, uterine fibroids, and benign prostatic hyperplasia (BPH) are some of the novel applications that businesses have looked into. These innovations seek to offer less intrusive alternatives to conventional treatment modalities.
In October 2023, The first radiofrequency balloon ablation catheter, the HELIOSTARTM Balloon Ablation Catheter, has been launched in Europe, according to Biosense Webster, Inc., a division of Johnson & Johnson MedTech.
In September 2021, The ICEfx Cryoablation System, a minimally invasive tool used to treat tumors and other vascular problems, was introduced by BTG International. By freezing tissue with liquid nitrogen, the gadget stops blood flow and kills aberrant cells.
VASCULAR EMBOLOTHERAPY MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
6% |
|
Segments Covered |
By Product Type, Indication, End-User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Terumo Corporation, Medtronic plc, BTG International Ltd. (Part of Boston Scientific Corporation), Stryker Corporation, Cook Medical Inc., Merit Medical Systems Inc., Johnson & Johnson (Cerenovus), Penumbra Inc., Boston Scientific Corporation, Cardinal Health Inc. |
Microspheres
Embolic coils
Embolic Plug Systems
Detachable Ballons
Liquid Embolic Agents
Others
Small, spherical particles called microspheres are employed in embolization operations to stop or limit blood flow to certain locations. They are frequently constructed from biocompatible substances like gelatin or acrylic. Small metallic coils or wires called embolic coils are inserted into blood arteries to encourage clotting and stop blood flow. They are often employed in the management of vascular abnormalities and aneurysms. Devices called embolic plug systems are made to physically block off blood vessels or shunts. To stop the blood flow, these systems may use plug-like devices that are inserted through catheters. Inflatable devices called detachable balloons can be put into blood arteries and used to either temporarily or permanently obstruct blood flow. They are frequently employed in the management of aneurysms and arteriovenous malformations. Injectable compounds called liquid embolic agents are used to obstruct blood arteries. These substances have the potential to harden or polymerize after injection, thereby obstructing blood flow.
Peripheral Vascular Disease
Neurovascular Disease
Oncology
Uterine Fibroids
Varicocele
Others
The treatment of diseases that affect the peripheral arteries, includes arteriovenous malformations (AVMs), deep vein thrombosis (DVT), and peripheral arterial disease (PAD). Techniques for vascular embolotherapy are applied to occlude or stop blood flow in the damaged arteries. the treatment of diseases that damage the brain's and central nervous system's blood vessels. Arteriovenous malformations (AVMs), intracranial aneurysms, and other neurovascular diseases are all treated with vascular embolotherapy. In the field of interventional oncology, vascular embolotherapy is essential. The blood supply to tumors is blocked by embolic agents, denying them nutrition and causing tumor necrosis or shrinking. This method is frequently used to treat solid tumors including liver cancer (hepatic embolization), renal cancer, and others. A minimally invasive alternative to surgical excision of fibroids is vascular embolization, sometimes referred to as uterine fibroid embolization (UFE) or uterine artery embolization (UAE). It includes restricting blood supply to the fibroids, which causes them to contract and relieves symptoms.
Hospitals
Clinics
Ambulatory surgical centers
Others
Patients in hospitals are the most common recipients of vascular embolotherapy treatments. They have the facilities, trained medical personnel, and equipment to carry out even the most intricate embolization treatments. Hospitals represent a sizable portion of the market because of the variety of embolization treatments they offer and the volume of patients they serve. The vascular embolotherapy industry also includes clinics, both general and specialist, as well as outpatient facilities. Outpatient treatment is provided by these clinics, which may have a specialized specialization like interventional radiology or vascular surgery. Patients who need embolization procedures that do not need hospitalization will appreciate their accessibility and ease of use. Same-day surgical techniques, such as vascular embolotherapy, are available at ASCs, or ambulatory surgery centers. The high quality of care provided at a low cost is what has made ASCs so popular. For those in need of less involved embolization treatments, these clinics are a great option for hospitals.
North America
Europe
Asia Pacific
Middle East and Africa
South America
North America, Europe, Asia-Pacific, South America, and the Middle East & Africa are the five main geographical categories that make up the embolotherapy market. The important factors driving the market expansion in this area are the growing presence of key market players in the region to seize the rising possibilities presented by these nations, as well as the improving healthcare infrastructure in the region and the huge patient population for target illnesses. The United States-based company Boston Scientific Corporation has a sizable part of the embolotherapy industry. To expand its customer base and product line, the corporation puts most of its efforts towards growth methods including acquisitions and expansions. The purchase of BTG has also contributed to the company's rising revenues and expanding market share. This is a key reason why Boston Scientific will be able to increase its selection of BTG products used in chemoembolization, radioembolization, and ablation treatments. Boston Scientific is persistent in its pursuit of governmental and insurance company approvals. The company's long-term growth plan includes expanding into and investing in fast-growing areas, such as the worldwide healthcare industry.
Global Vascular Embolotherapy Market Key Players:
Terumo Corporation
Medtronic plc
BTG International Ltd. (Part of Boston Scientific Corporation)
Stryker Corporation
Cook Medical Inc.
Merit Medical Systems Inc.
Johnson & Johnson (Cerenovus)
Penumbra Inc.
Boston Scientific Corporation
Cardinal Health Inc.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global Vascular Embolotherapy Market was estimated to be worth USD 3.8 Billion in 2022 and is projected to reach a value of USD 7.03 Billion by 2030, growing at a CAGR of 6% during the outlook period 2023-2030.
The Global Vascular Embolotherapy Market is majorly driven by Increasing Prevalence of Vascular Diseases, Increasing Prevalence of Vascular Diseases, Increasing Prevalence of Vascular Diseases, Increasing Geriatric Population
The Segments under the Global Vascular Embolotherapy Market by Indication are Retail, Food and Beverage, and Pharmaceuticals.
China, Japan, South Korea, Singapore, and India are the most dominating countries in the Asia Pacific region for the Global Vascular Embolotherapy Market.
Terumo Corporation, Medtronic plc, and BTG International Ltd. are the three major leading players in the Global Vascular Embolotherapy Market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
